To validate the protein-level expression patterns of the prognostic genes in clinical specimens, we performed immunohistochemical (IHC) staining of MAOB, IGFBP2, SERPINA1, and LGR6 on paraffin-embedded sections of glioma tissues and adjacent non-tumorous brain tissues. This evidence concerns the gene IGFBP2 and central nervous system cancer.